New Long-Acting shot for schizophrenia enters early human testing
Disease control
Recruiting now
This early-stage study is testing a single dose of a long-acting injectable form of the drug brexpiprazole in healthy volunteers and people with schizophrenia. The main goal is to see if the injection is safe and tolerable, and how the body processes the drug. The study involves …
Phase: PHASE1 • Sponsor: Sichuan Kelun Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 12:08 UTC